Cancer Focus Fund Investment Team

  • Ross P. Barrett, Managing Partner

    Ross is the Managing General Partner of the Cancer Focus Fund, LP. He has started and overseen several VC funds, and is co-founder of a data analytics firm that tracks venture-backed firms. [More]

  • Jonathan Fassberg, Investment Committee

    Jonathan Fassberg is Vice Chairman - Healthcare Investment Banking at Oppenheimer & Co. Inc. He was formerly the Co-Chief Executive Officer of the Solebury Trout Group and in charge of Deal Scouting for the Fund’s Investor Committee. [More]

  • Jaime Aguirre, Investment Committee

    Jaime Aguirre is the Chief Investment Officer of Atlas Capital Global, and an independent advisor to a Mexican pension fund with over $50 billion in assets. [More]

  • Jennifer Pou, Principal

    Jennifer’s responsibilities at CFF include performing financial modeling and analysis, assisting the Investment Committee with their due diligence process and managing communication with investors. [More]

  • Hector Alila, D.V.M. Ph.D., Venture Partner

    Dr. Alila has more than 30 years of senior management experience in drug development in large pharmaceutical and biotech companies and academic research. [More]

  • David R. Epstein, Advisor

    David Epstein serves on the Healthcare Advisory Board of J.P. Morgan Life Sciences Private Capital. He was CEO of Seagen before its sale to Pfizer in December 2023. [More]

  • Michael Margolis, Capital Markets Advisor

    Head of Life Sciences and Co-Head of Healthcare Investment Banking at Oppenheimer & Co. [More]

  • Andrea Alms, Venture Partner

    Andrea is Venture Partner and head of Investor Relations at Cancer Focus Fund. [More]

MD Anderson Cancer Center Operations Team

  • Ferran Prat

    Ferran is responsible for linking MD Anderson and industry partners. His efforts generate collaborations that bring new drugs, diagnostics, imaging agents and IT solutions to market faster, benefiting patients suffering from cancer. [More]

  • Shara Avis Pecoraro

    Shara establishes direct contact within the pharmaceutical and biotech industry, domestically and internationally, in order to bring new preclinical studies, clinical trials, creative financial deals, collaborations, and alliances to MD Anderson. [More]

  • Cassandra Moyer

    Cassandra is Odyssey Fellow at MD Anderson Cancer Center